Association of non-selective β blockers with the mortality risk in decompensation cirrhosis: a systematic review and meta-analysis. [PDF]
Front PharmacolZhang J, Lin Y, Weng X.
europepmc +1 more source
Non-Selective Beta-Blocker Use Is Associated With Lower Mortality After Decompensation in Cirrhosis: A Nationwide Target Trial Emulation. [PDF]
Aliment Pharmacol TherSong BG +6 more
europepmc +1 more source
Protective effects of beta-blockers against anthracycline- and trastuzumab-related cardiotoxicity: a systematic review based on conventional and Bayesian network meta-analysis. [PDF]
Front Cardiovasc MedJiang S, Gao G.
europepmc +1 more source
Closing the screening gap but not the writing gap: a two-topic evaluation of LLMs for systematic reviews and meta-analyses in hepatology. [PDF]
NPJ Gut LiverZou Y, Kim I, Gao N, Li M, Kim MO, Ge J.
europepmc +1 more source
Dilated and Noncompaction Cardiomyopathy in a Pediatric Patient With Maternal CASZ1 Variant. [PDF]
JACC Case RepSekiguchi L +3 more
europepmc +1 more source
Carvedilol for Prevention of Chemotherapy-Induced Cardiotoxicity: Final Results of the CECCY Trial. [PDF]
JACC CardioOncolAyub-Ferreira SM +9 more
europepmc +1 more source
Efficacy of high-dose carvedilol treatment for cats with stage B1 obstructive hypertrophic cardiomyopathy. [PDF]
J Feline Med SurgSatomi S +6 more
europepmc +1 more source
Preventing First and Further Decompensation in Advanced Chronic Liver Disease. [PDF]
Liver IntSüffert LC +2 more
europepmc +1 more source
Comparison of Long-Term Clinical Outcomes Between Immediate-Release and Slow-Release Carvedilol: A National Real-World Database Analysis. [PDF]
J Clin MedKim HL, Joh HS, Kim SH.
europepmc +1 more source
Therapeutic progress in rosacea: targeting the neuro-vascular-immune triad. [PDF]
Front ImmunolYang X, Yang W, Chen N, Li D, Xu Y.
europepmc +1 more source